Neurologic conditions such as multiple sclerosis, myasthenia gravis, autoimmune polyneuropathy, and chronic migraine often require advanced biologic or specialty infusion treatments. At Infused Health, we provide safe, efficient administration of these therapies in a welcoming, outpatient setting—designed with comfort and coordination in mind.

​

Our clinical team works closely with neurologists and referring specialists to ensure patients receive timely, personalized care.

​

Current Therapies Offered

Multiple Sclerosis (MS)

• BRIUMVI®—Anti-CD20 therapy for relapsing forms of MS

• OCREVUS®/OCREVUS ZUNOVO™—Disease-modifying therapy for relapsing and primary progressive MS

• TYSABRI®—For relapsing MS and Crohn’s disease; helps reduce MS relapses and delay progression

Myasthenia Gravis

• RYSTIGGO®—FcRn blocker for generalized myasthenia gravis in adults with AChR or MuSK antibodies

• SOLIRIS®—Complement inhibitor for treatment of AChR+ generalized myasthenia gravis

• VYVGART®/VYGART®HYTRULO—FcRn inhibitor for gMG; used to reduce disease-causing antibodies

Neurologic Autoimmune and Inflammatory Conditions

• BIVIGAM®—IVIG for primary humoral immunodeficiency; sometimes used off-label in neurologic immune conditions

• PANZYGA®—IVIG approved for CIDP, primary immunodeficiency, and chronic ITP

• RITUXAN®—Used in neurologic autoimmune vasculitis (e.g., GPA, MPA), also for RA, NHL, and CLL

• RUXIENCE®—Biosimilar to Rituxan® with same indications

• AMVUTTRA®—RNAi therapy for hereditary transthyretin amyloidosis (hATTR) with polyneuropathy

Chronic Migraine

• VYEPTI®—IV CGRP-inhibitor for prevention of chronic and episodic migraine; given every 3 months

Shared Therapies (Also Used in Rheum/Gastro)

• AVSOLA®, INFLECTRA®, RENFLEXIS®—Biosimilars to infliximab used for inflammatory arthritis, Crohn’s, ulcerative colitis, and in select neuro-autoimmune cases

​

​

Providers: Click on any medication name below to download the referral form.